Disease | barrett esophagus |
Comorbidity | C0017168|esophageal reflux disease |
Sentences | 6 |
PubMedID- 25632808 | Adiponectin may modify the risk of barrett's esophagus in patients with gastroesophageal reflux disease. |
PubMedID- 20931428 | Conclusions: patients with progressive systemic sclerosis have a higher tendency to the more severe forms and complications of gastroesophageal reflux disease including barrett's esophagus than in those without progressive systemic sclerosis. |
PubMedID- 20086178 | Gastroesophageal reflux disease complicated by barrett's esophagus (be) is a major risk factor for esophageal adenocarcinoma (ea). |
PubMedID- 23504527 | barrett's esophagus, with gastroesophageal reflux disease and obesity as risk factors, predisposes to esophageal adenocarcinoma (eac). |
PubMedID- 23679035 | In young adults gastroesophageal reflux disease occurs frequently with development of barrett esophagus in 6% reported in different series. |
PubMedID- 25804032 | [prospects for improving the management tactics for patients with gastroesophageal reflux disease complicated by barrett's esophagus]. |
Page: 1